BORDI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 1.999
EU - Europa 1.440
AS - Asia 830
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
OC - Oceania 1
Totale 4.279
Nazione #
US - Stati Uniti d'America 1.952
CN - Cina 587
IE - Irlanda 337
UA - Ucraina 285
SE - Svezia 274
FI - Finlandia 249
DE - Germania 149
SG - Singapore 114
TR - Turchia 70
GB - Regno Unito 55
IT - Italia 54
IN - India 52
CA - Canada 47
BE - Belgio 19
EU - Europa 6
FR - Francia 6
IR - Iran 5
RU - Federazione Russa 3
CI - Costa d'Avorio 2
NL - Olanda 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
LT - Lituania 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 4.279
Città #
Chandler 375
Dublin 337
Jacksonville 315
Beijing 140
Dearborn 138
Ashburn 120
Ann Arbor 116
Boardman 95
Singapore 85
Nanjing 83
San Mateo 69
Princeton 68
Izmir 67
Shanghai 58
Pune 48
Wilmington 45
Toronto 43
Woodbridge 35
Kunming 33
Nanchang 30
Helsinki 26
Jinan 25
Shenyang 24
New York 22
Parma 21
Brussels 19
Hebei 19
Los Angeles 19
Hefei 18
Tianjin 18
Jiaxing 15
Changsha 14
Hangzhou 13
Santa Clara 13
Guangzhou 12
Auburn Hills 11
Bremen 10
Des Moines 9
Haikou 9
Chengdu 7
Dallas 7
Lanzhou 6
Norwalk 6
Wenzhou 6
Zhengzhou 6
Ningbo 5
Seattle 5
Borås 4
Fremont 4
Fuzhou 4
Houston 4
Rio Saliceto 4
Taizhou 4
Andover 3
Baotou 3
Falls Church 3
Kocaeli 3
London 3
Ottawa 3
Rockville 3
Abidjan 2
Clifton 2
Düsseldorf 2
Kashan 2
Leawood 2
Luzzi 2
Marseille 2
Sacramento 2
Taiyuan 2
Xian 2
Amsterdam 1
Augusta 1
Bangalore 1
Budapest 1
Cairo 1
Changchun 1
Chaoyang 1
Chiayi County 1
Chicago 1
Chongqing 1
Copenhagen 1
Cormeilles-en-Parisis 1
Gatchina 1
Grafing 1
Harbin 1
Henderson 1
Huzhou 1
Las Vegas 1
Madrid 1
Medolla 1
Melbourne 1
Montréal 1
Mumbai 1
Munich 1
North Charleston 1
Omsk 1
Orange 1
Prague 1
Quzhou 1
Ramenskoye 1
Totale 2.760
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 111
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 97
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 94
Classification of gastric endocrine cells at the light and electron microscopical levels 93
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 86
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 82
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 82
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 80
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 79
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 79
Endocrine tumors of the gastrointestinal system 78
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 78
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 77
Poorly differentiated endocrine carcinoma 76
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 76
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 75
Classification of neuroendocrine tumours 74
Pleomorph poorly differentiated endocrine carcinoma of the rectum 73
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 72
Biclonality of gastric lymphomas 71
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 71
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 70
Aetiology, molecular pathogenesis and genetics 70
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 69
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 68
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 68
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 67
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 66
Criteria for malignancy in gastrointestinal endocrine tumors 66
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 66
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 66
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 65
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 65
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 65
Multiple endocrine neoplasia type 1 63
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 63
Non-functioning tumours and microadenomas 62
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 62
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 62
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 61
Pancreatic endocrine tumours: Introduction 60
Different patterns of 11q allelic losses in digestive endocrine tumors 60
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 59
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 57
Multiple endocrine neoplasia (MEN)-associated tumours 56
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 55
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 54
Gastrinomas 53
Mixed exocrine-endocrine carcinomas 53
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 52
Highlights on biology of endocrine tumours of the gut and pancreas 52
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 50
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 50
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 50
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 48
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 47
Prognostic factors in gastrointestinal endocrine tumors 47
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 47
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 46
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 45
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 44
Hypergastrinemia and gastric enterochromaffin-like cells 43
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 40
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 38
The normal endocrine cell of the gut. Changing concepts and new evidences 34
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 33
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 32
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 32
Totale 4.285
Categoria #
all - tutte 14.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020612 0 0 0 26 81 98 114 20 90 97 14 72
2020/2021465 4 65 64 7 63 4 62 4 104 14 69 5
2021/2022367 11 2 2 26 13 7 48 64 17 31 46 100
2022/20231.269 147 135 55 107 114 141 16 73 428 4 37 12
2023/2024414 29 41 5 2 37 153 22 29 5 21 24 46
2024/2025200 18 78 91 13 0 0 0 0 0 0 0 0
Totale 4.285